Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections-Reference-Cited by-同舟云学术

Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections

Published:2021-12 Issue: Volume:113 Page:279-281
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Sader Helio S.,Castanheira Mariana,Duncan Leonard R.,Mendes Rodrigo E.

Funder

Pfizer Inc Boulder

Pfizer

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference10 articles.

1. Gram negative wound infection in hospitalised adult burn patients–systematic review and metanalysis;Azzopardi;PLoS One,2014

2. Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution;Botelho;Drug Resist Updat,2019

3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: eleventh edition M07,2018

4. Novel antibiotic treatment for skin and soft tissue infection;Dryden;Curr Opin Infect Dis,2014

5. EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0, January 2021. January 1, 2021 ed: European Committee on Antimicrobial Susceptibility Testing; 2021.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections: a single-center preliminary experience;Frontiers in Microbiology;2024-07-16

2. Influence of seasonality and habitat on chemical composition, cytotoxicity and antimicrobial properties of the Libidibia ferrea;Heliyon;2024-05

3. Global Resistance of Imipenem/Relebactam against Gram-Negative Bacilli: Systematic Review and Meta-Analysis;Current Therapeutic Research;2024

4. In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012–2021;International Journal of Antimicrobial Agents;2023-08

5. Ceftolozane/tazobactam heteroresistance in cystic fibrosis-relatedPseudomonas aeruginosainfections;JAC-Antimicrobial Resistance;2023-07-11